News

New biotech facility Hummingbird Bioscience opens

Continue Reading

王瑞杰出席“蜂鸟”生物医药科研设施开幕：引进全球人才有助我国打造科研绿洲

Continue Reading

Biomed start-up Hummingbird Bioscience opens new facility to boost its R&D work

Continue Reading

HER3-addicted tumors: how biotechs are closing in

Continue Reading

Scrip interview with Piers Ingram, CEO of Hummingbird Bioscience

Continue Reading

Eyeing clinical proof-of-concept for HER3 drug, Amgen-partnered biotech scores $125M for precision antibodies

Continue Reading

Hummingbird CEO and Co-Founder Piers Ingram speaks to PharmaBoardroom in exclusive interview

Continue Reading

[Asia Healthcare Podcast Interview] Our CEO and CO-Founder Piers Ingram discusses how systems biology and data science have advanced the understanding of disease, and how Hummingbird’s unique multidisciplinary approach unites the power of these two fields to create revolutionary therapies.

Continue Reading

[DealStreetAsia Interview] Hummingbird speaks to DealStreetAsia about the company’s overall drug development this year and its positive outlook on future investments.

Continue Reading

Hummingbird Bioscience has been recognized with the Most Promising Innovation title at Singapore’s SG:D Techblazer Awards 2020, the nation’s highest accolade for tech innovation.

Continue Reading